![>](style_images/Executiv-909/nav_m.gif)
Teva buying Cephalon for $6.8 billion
(AP)
Biotechnology News
AP - Teva Pharmaceutical Industries Ltd. has agreed to buy Cephalon Inc. for $6.8 billion in a deal that would give the world's largest generic drug developer a range of biotechnology drugs aimed at cancer and other conditions.
Source: Yahoo! News: Biotechnology News